Coface Stock in 2026: Price, Dividend and Outlook

Coface stock (ticker COFA, Euronext Paris, ISIN FR0010667147) is the least-known income stock on the Paris market: this credit insurance specialist, which protects companies against unpaid customer invoices, trades at €15.41 with an estimated 2026 yield of 7.86% — a level now found almost only among large cyclical energy or banking stocks.

The investment case for Coface stock in 2026 comes down to two lines that do not sit well together: on one side, a yield well above the market; on the other, a stock down 9.09% over one month, just as rumours of an acquisition by a French insurer resurface in the newswires. Between a coveted dividend and a worrying pullback, this profile covers it all: business, figures, consensus, risks and the buying decision.

Coface Share Price Live

Coface is listed on Euronext Paris, in euros. The stock is eligible for the SRD deferred settlement service and the PEA — a valuable advantage for an income stock, as dividends held in the account escape securities-account taxation throughout the capital-building phase.

As of 23 October 2026, Coface stock trades at €15.41, down 0.32% on the day. The short term is gloomy: −3.14% over one week and −9.09% over one month. The medium term is almost as weak: −4.70% over three months and −4.35% over six months. The one-year window then closes almost flat, at −0.52% — proof that the stock held its ground through twelve chaotic months before giving way recently.

Longer periods are a reminder that Coface is no sleepy stock: +36.16% over three years, +22.61% over five years and +148.39% over ten years. Halfway between a defensive stock and a dynamic small cap, it has more than doubled investors’ money over the decade — excluding dividends, which roughly double again the scale of the return actually received by patient shareholders.

ISINFR0010667147
Exchange and tickerParis — cofa.pa
SectorFinancial Services

COFACE SACOFA.PA · Paris
15,72 €-2,72 %
Clôture précédente16,16 €
Plus haut du jour16,10 €
Plus bas du jour15,50 €
Plus haut 52 semaines17,62 €
Plus bas 52 semaines14,19 €
Volume77 993
Capitalisation2,4 Md
PER11,6
Rendement du dividende7,84 %
Dividende par action1,25 €
Objectif moyen des analystes18,25 €
Mis à jour le 2026-11-19 15:45:46 · Source : Yahoo · Données indicatives, ne constituent pas un conseil en investissement.

Historique des dividendes — COFACE SA
Date de détachementMontant par action
2026-05-261,250 €
2025-05-201,400 €
2024-05-221,300 €
2023-05-221,520 €
2022-05-201,500 €
Source : Yahoo Finance · Collecté le 2026-11-19 14:45:47 UTC · Données historiques indicatives, non temps réel.

Yahoo Finance — data checked on 23/10/2026: price and fundamentals, ex-dividend history. Market data is indicative and does not constitute investment advice.

To compare with other insurance stocks, see also our analysis of Donegal Group stock.

Coface Stock Profile

CompanyCoface S.A.
TickerCOFA (Euronext Paris)
ISINFR0010667147
ExchangeEuronext Paris (in euros)
SectorInsurance — credit insurance and trade risk management
PEA / SRD eligibilityYes / Yes
Share price (23 October 2026)€15.41
Estimated 2026 yield7.86%
Consensus target€18.25 (+18.89%)

The business: insuring against unpaid trade invoices

Coface insures companies against the risk of their customers not paying. When a manufacturer sells to a distributor on sixty-day payment terms, credit insurance guarantees it will be paid even if the customer defaults. The business also covers company information — assessing the financial strength of millions of companies — and debt collection when a claim arises.

It is a conceptually high-quality model. The premium is collected today and any claim comes later: in between, the credit insurer lives on a float which, properly managed, earns as much as the insurance business itself. There is also a subtle countercyclical effect: when the economy slows, bankruptcies rise and claims weigh on the accounts, but demand for insurance soars — every company suddenly wants to protect its receivables.

The Coface brand adds a further intangible asset: founded nearly eight decades ago as the public insurer of French foreign trade, the company has supported generations of exporters. This heritage has given it a company information network and an international footprint that no new entrant can replicate in a few years — the barrier to entry lies in the data, not the insurance policy.

The second pillar of the model deserves special attention: company data. Assessing millions of companies worldwide requires teams of credit analysts, scoring models and information sources that only a handful of global players have managed to build up. This information base feeds premium pricing, the selection of insured risks and the early detection of defaults — it is, at heart, the firm’s real strategic asset, even more than its portfolio of contracts.

History: from public insurer to Paris listing

Created after the war to guarantee French exports, Coface was privatised in stages, coming under the control of a French banking group for two decades before being floated on the Paris stock exchange. The listing transformed its status: from a state tool turned bank subsidiary, it became an independent listed company, judged every quarter on its own results.

The stock’s subsequent trajectory has rewarded consistency. No spectacular narrative and no collapse: steady progress, driven by regular dividend payments and a business that grows with world trade — that of SMEs as well as large groups. Over ten years, its +148.39% performance places the stock in the select group of French small and mid caps that patiently create value.

The Dividend: The Core of the Investment Case

The estimated 2026 yield is 7.86%: this is the figure that drives the buy case, and it deserves unpacking. Such a level means two things at once. First, that the payout is generous relative to expected earnings — credit insurance is a highly cash-generative business that requires little heavy capital spending. Second, that the market has doubts: such a high yield also reflects a share price held down by mistrust.

Comparing it with emblematic income stocks clarifies where Coface stands. TotalEnergies and its oil dividend offer a more moderate yield but backed by enormous cash flows; large defensive consumer stocks such as Danone and its defensive food profile combine an average yield with visibility. Coface is in a category of its own: a higher yield, a smaller market cap and exposure to the trade credit cycle.

For investors who reinvest, the mechanism is powerful: at 7.86% reinvested every year, the yield on cost doubles in about nine years — with no assumption of share price growth or dividend increases. This quiet arithmetic is what makes well-built dividend portfolios successful, provided the payout survives the cycles.

Two indicators are then enough to track the health of the engine: the loss ratio — claims paid relative to premiums earned — and growth in new business. A stable loss ratio on growing premiums confirms that the income stream is working; a drift in either line generally signals, two quarters later, a revision of the dividend expected by the market.

The CNP Assurances Rumour: A Catalyst to Take Seriously?

In early October 2026, newswires reported that a major French life and protection insurer — CNP Assurances — was “considering” acquiring Coface. The stock reacted as takeover targets always do: a jump, followed by a pullback as doubts set in. As of 23 October, the month’s decline (−9.09%) reflects these renewed questions.

A rational reading of such a rumour calls for three reflexes. First: consolidation in insurance is plausible — the sector is consolidating across Europe, and a profitable, small-cap credit insurer ticks many boxes as an ideal target. Second: “considering” does not mean “offering”, and many rumours die for lack of an agreed price. Third: even if nothing comes of it, the rumour signals that the stock is attracting the attention of industrial buyers — a de facto floor for the valuation.

Income investors will take away the main lesson: the downside risk on the stock is partly offset by this potential for an industrial deal. Speculators, meanwhile, will play the rumour cautiously — knowing that a formal denial can wipe out a week’s gains in a single session.

Stock Market Performance: The Full Picture

PeriodPerformance
1 week−3.14%
1 month−9.09%
3 months−4.70%
6 months−4.35%
1 year−0.52%
3 years+36.16%
5 years+22.61%
10 years+148.39%

The structure of the table describes a stock on pause, not broken down: longer periods remain clearly positive, the one-year window is almost flat, and only the last month shows a marked drop. Technical analyses published on market newswires reflect the same indecision — sometimes “bullish signals remain intact”, sometimes “a pullback towards support is likely”, depending on the day and the levels.

This kind of setup — an income stock consolidating after a long rise — is typical ahead of results releases. The market is waiting for the accounts, the takeover rumour is circulating, and the stock swings with both. For long-term buyers, these swings offer entry points; for traders, noise that is hard to exploit.

Tableau originalDiversifiez votre patrimoineInvestissez dans l’artDes tableaux originaux, pièces uniques signées par l’artiste. Un actif tangible, loin des écrans et des cotations.Voir les tableaux →

Analyst Consensus on Coface Stock

As of 18 October 2026, research coverage is thin — just four analysts:

RecommendationNumber of analysts
Buy2
Outperform0
Hold2
Underperform0
Sell0

The median target is €18.25, implying +18.89% upside — to which, of course, the estimated 7.86% yield must be added: together, they point to a potential return of more than 25% over twelve months if the central scenario plays out. Thin coverage is not a flaw in itself: it mainly means that a small cap attracts less interest from investment banks, and that the stock can stay below its target for a long time without anyone taking much notice.

Recent consensus trends can also be seen in recommendations reported on the newswires: target changes alternate with technical analyses, a sign of a stock followed more for its yield than for its rerating potential. This is consistent with the nature of the business — credit insurance produces steady results, not spectacular surprises.

Risks to Know Before Buying

Cyclical risk first: credit insurance is cyclical by nature. A prolonged recession increases business failures and therefore claims, making the dividend stream more fragile than it seems. Interest rate risk next: like any income stock, it suffers when interest rates make bonds competitive — a 7.86% dividend is more impressive when risk-free assets yield little.

Liquidity risk too: for a mid cap covered by four analysts, institutional fund flows are enough to move the share price by several percent — as the 9.09% drop over the last month shows. Finally, rumour risk: until the CNP lead is either confirmed or dropped, the stock will move to the rhythm of unverified news, with swings that long-term investors must be prepared to ride out without reacting.

How to Buy Coface Stock

If you are new to investing, our guide on how to invest in the stock market covers the basics. Buying the stock then takes five steps:

  1. Preferably open a PEA with a regulated broker — our comparison of reliable, trustworthy trading platforms details fees and execution quality.
  2. Search for the stock using the ticker COFA or the ISIN FR0010667147.
  3. Turn on dividend reinvestment if your broker offers it: with an estimated 7.86% yield, automatic compounding is the core of the investment case.
  4. Place a limit order: on an income stock covered by few analysts, every basis point of price difference affects your entry yield.
  5. Follow the half-year results: loss ratio, cost of risk and amounts insured — three lines that show the real state of the engine.

Taxation

In a French standard securities account, dividends and capital gains are subject to the 30% flat tax (PFU), with the option of the progressive income tax scale. In a PEA, after five years of holding, the reinvested 7.86% dividend is subject only to the 17.2% social charges — the tax difference turns a good yield into a remarkable one, which is why the PEA is the natural choice for this stock.

Should You Buy Coface Stock in 2026?

The bull case: an estimated 7.86% yield — rare for a business of this quality — and a consensus target implying +18.89%; a takeover rumour that limits downside risk; and structurally profitable credit insurance fundamentals.

The cautious case: a 9.09% decline over one month that has not yet stabilised; thin research coverage (four analysts) that leaves the stock in the hands of a few players; sensitivity to the economic cycle and interest rates; and the uncertainty attached to any unconfirmed rumour.

Our verdict: Coface stock is a pure income stock, best placed in the income portion of a diversified portfolio. It does not promise double-digit annual gains; it promises — if the cycle allows — a high dividend stream, reinvested in a suitable tax account, with a potential takeover bonus. At €15.41, with a target of €18.25, the market is offering the yield; it is up to the investor to pay for it in patience.

Coface Stock FAQ

What is the Coface share price today?

As of 23 October 2026, Coface stock trades at €15.41 on Euronext Paris, down 0.32% on the day and 9.09% over the last month. Over three years, the stock is up 36.16%.

What is the Coface dividend yield in 2026?

The estimated 2026 yield is 7.86%, higher than most stocks on the French market. Reinvested each year in a PEA, this yield doubles the yield on cost in about nine years.

Is Coface stock a good investment in 2026?

The consensus as of 18 October 2026 is split: 2 of 4 analysts recommend buying, 2 recommend holding and none recommend selling, with a median target of €18.25 (+18.89%). The investment case rests on the yield and the steadiness of the credit insurance business.

Why has Coface stock fallen this month?

The 9.09% drop over one month follows the jump triggered by the rumoured acquisition by CNP Assurances, reported by newswires in early October. With no confirmation of the deal, the stock has given back part of its gains in an indecisive market.

Will CNP Assurances buy Coface?

No deal has been confirmed to date: newswires only report that CNP Assurances is “considering” the acquisition. Consolidation in insurance is plausible, but until an offer is published, the rumour alone should not be the basis for a buying decision.

Is Coface stock PEA-eligible?

Yes. As a French company listed on Euronext Paris, Coface is eligible for both the PEA and the SRD. After five years of holding, dividends and capital gains are subject only to the 17.2% social charges.

What is the stock’s exact listing?

The stock trades on Euronext Paris under the ticker COFA, ISIN FR0010667147. The “Share price” section of this profile brings together the full details and live tracking of the listing from France.

Conclusion: A Rare Yield, at the Price of Discipline

Coface stock combines something the French stock market offers less and less: a niche business with real barriers to entry, an estimated 7.86% yield and a decade of quiet value creation. The recent pullback and the takeover rumour complete the picture — one offering an entry point, the other a speculative floor.

The decision is yours, but the framework is clear: buying Coface means choosing income over narrative. It means accepting a stock that will not make headlines every month, that will pay its dividend with little fanfare — and that may one day reappear in the news for good industrial reasons. In a portfolio where growth stocks grab the attention, an income position with potential double-digit returns at least deserves a look, provided you monitor it with the same rigour as the rest of your portfolio.

Prices and data as of 23 October 2026 (Euronext Paris, Boursorama). The estimates cited are those of the analyst consensus and may be revised. This article is for information only and does not constitute investment advice: invested capital remains exposed to a risk of loss.

Suivez-nous sur Telegram